- Home
- CASI vs BNGO Comparison
CASI vs BNGO Comparison
Compare CASI & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASI
- BNGO
- Stock Information
- Founded
- CASI 1991
- BNGO 2003
- Country
- CASI China
- BNGO United States
- Employees
- CASI N/A
- BNGO N/A
- Industry
- CASI Biotechnology: Pharmaceutical Preparations
- BNGO Biotechnology: Laboratory Analytical Instruments
- Sector
- CASI Health Care
- BNGO Industrials
- Exchange
- CASI Nasdaq
- BNGO Nasdaq
- Market Cap
- CASI 20.5M
- BNGO 24.3M
- IPO Year
- CASI 1996
- BNGO 2018
- Fundamental
- Price
- CASI $1.40
- BNGO $3.40
- Analyst Decision
- CASI Strong Buy
- BNGO Buy
- Analyst Count
- CASI 1
- BNGO 5
- Target Price
- CASI $4.00
- BNGO $7.33
- AVG Volume (30 Days)
- CASI 313.5K
- BNGO 84.1K
- Earning Date
- CASI 08-15-2025
- BNGO 08-06-2025
- Dividend Yield
- CASI N/A
- BNGO N/A
- EPS Growth
- CASI N/A
- BNGO N/A
- EPS
- CASI N/A
- BNGO N/A
- Revenue
- CASI $31,368,000.00
- BNGO $28,464,000.00
- Revenue This Year
- CASI N/A
- BNGO N/A
- Revenue Next Year
- CASI N/A
- BNGO $15.54
- P/E Ratio
- CASI N/A
- BNGO N/A
- Revenue Growth
- CASI 8.39
- BNGO N/A
- 52 Week Low
- CASI $1.09
- BNGO $2.68
- 52 Week High
- CASI $7.67
- BNGO $41.33
- Technical
- Relative Strength Index (RSI)
- CASI 44.81
- BNGO 47.05
- Support Level
- CASI $1.23
- BNGO $3.22
- Resistance Level
- CASI $1.50
- BNGO $3.46
- Average True Range (ATR)
- CASI 0.12
- BNGO 0.15
- MACD
- CASI 0.03
- BNGO 0.02
- Stochastic Oscillator
- CASI 78.05
- BNGO 75.86
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.